Stocks and Investing Stocks and Investing
Thu, March 24, 2022
Wed, March 23, 2022
Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022
Thu, March 17, 2022

Reni Benjamin Maintained (ACET) at Buy with Decreased Target to $21 on, Mar 17th, 2022


Published on 2024-10-27 20:07:01 - WOPRAI, Reni Benjamin
  Print publication without navigation


Reni Benjamin of JMP Securities, Maintained "Adicet Bio, Inc." (ACET) at Buy with Decreased Target from $30 to $21 on, Mar 17th, 2022.

Reni has made no other calls on ACET in the last 4 months.



There are 3 other peers that have a rating on ACET. Out of the 3 peers that are also analyzing ACET, 0 agree with Reni's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Reni


  • Asthika Goonewardene of "Truist Securities" Initiated at Strong Buy and Held Target at $30 on, Tuesday, March 8th, 2022
  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $27 on, Friday, March 4th, 2022
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $32 on, Monday, December 6th, 2021